Ferreira Carlos, Poretti Andrea, Cohen Julie, Hamosh Ada, Naidu Sakkubai
National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.
Am J Med Genet A. 2014 Jul;164A(7):1802-7. doi: 10.1002/ajmg.a.36526. Epub 2014 Apr 4.
Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) has recently been associated with a single heterozygous p.D249N mutation in TUBB4A. We describe two novel mutations in this gene. A p.C239F mutation was found in one of the originally described H-ABC patients, for whom we provide follow-up 11 years after the original publication. The second novel mutation, p.R262H, was found in a patient with a typical clinical presentation for H-ABC, but with a novel neuroimaging phenotype, given the absence of atrophy of the putamen and caudate nucleus despite 7 years of follow-up. The recent recognition of TUBB4A mutations as the underlying etiology of H-ABC will likely lead to the identification of subtler clinical and neuroimaging presentations of this disorder, like in our third patient. Thus mutations in this gene should be suspected in any patient with hypomyelination, regardless of the long-term presence of neostriatal atrophy.
基底神经节和小脑髓鞘形成低下伴萎缩(H-ABC)最近被认为与TUBB4A基因中的一个杂合p.D249N突变有关。我们描述了该基因中的两个新突变。在最初描述的H-ABC患者之一中发现了p.C239F突变,我们在最初发表11年后对其进行了随访。第二个新突变p.R262H是在一名具有H-ABC典型临床表现的患者中发现的,但具有一种新的神经影像学表型,因为尽管经过7年随访,壳核和尾状核并无萎缩。最近认识到TUBB4A突变是H-ABC的潜在病因,这可能会导致识别出该疾病更细微的临床和神经影像学表现,就像我们的第三位患者那样。因此,对于任何有髓鞘形成低下的患者,无论是否长期存在新纹状体萎缩,都应怀疑该基因存在突变。